Annovis Bio Inc
ANVS2.610USD
+0.100+3.98%
交易中 （美東）報價延遲15分鐘
50.86M總市值
虧損本益比TTM
關於 Annovis Bio Inc 公司
Annovis Bio, Inc. 是一家臨牀階段藥物平臺公司，致力於治療神經退行性疾病，如阿爾茨海默病 (AD)、帕金森病 (PD) 和其他慢性神經退行性疾病。該公司正在開發其主要候選產品 Buntanetap，旨在治療 AD、PD 和其他潛在的慢性神經退行性疾病。Buntanetap 是一種合成的小分子口服腦滲透性化合物。其候選產品 ANVS405 是一種靜脈注射藥物，正在開發用於急性適應症，專注於保護創傷性腦損傷 (TBI) 和/或中風後的大腦。ANVS405 與 Buntanetap 是同一種化合物，用於治療急性頭部和腦部創傷。ANVS301 是一種口服藥物，正在開發用於提高 AD 和癡呆症後期的認知能力。ANVS301 被觀察到通過將錯誤數量從六個減少到三個來改善高齡大鼠的記憶力和學習能力。
公司簡介
公司代碼ANVS
公司名稱Annovis Bio Inc
上市日期Jan 29, 2020
CEODr. Maria L. Maccecchini, Ph.D.
員工數量8
證券類型Ordinary Share
年結日Jan 29
公司地址101 Lindenwood Drive, Suite 225
城市MALVERN
上市交易所NYSE Consolidated
國家United States of America
郵編19355
電話14848753192
網址https://www.annovisbio.com/
公司代碼ANVS
上市日期Jan 29, 2020
CEODr. Maria L. Maccecchini, Ph.D.
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Michael B. Hoffman
Mr. Michael B. Hoffman
Independent Chairman of the Board
Independent Chairman of the Board
1.67M
+1.52%
Mr. Andrew Walsh
Mr. Andrew Walsh
Vice President - Finance, Principal Financial Officer
Vice President - Finance, Principal Financial Officer
500.00
--
Dr. Maria L. Maccecchini, Ph.D.
Dr. Maria L. Maccecchini, Ph.D.
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
--
--
Dr. Claudine E. Bruck, Ph.D.
Dr. Claudine E. Bruck, Ph.D.
Independent Director
Independent Director
--
--
Mr. Reid S. Mccarthy
Mr. Reid S. Mccarthy
Independent Director
Independent Director
--
--
Mr. Mark White
Mr. Mark White
Director, Chief Business Officer
Director, Chief Business Officer
--
--
Eve Damiano
Eve Damiano
Senior Vice President - Regulatory
Senior Vice President - Regulatory
--
--
,
,
Vice President - Process Chemistry
Vice President - Process Chemistry
--
--
Cheng Fang
Cheng Fang
Senior Vice President - Research and Development
Senior Vice President - Research and Development
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Michael B. Hoffman
Mr. Michael B. Hoffman
Independent Chairman of the Board
Independent Chairman of the Board
1.67M
+1.52%
Mr. Andrew Walsh
Mr. Andrew Walsh
Vice President - Finance, Principal Financial Officer
Vice President - Finance, Principal Financial Officer
500.00
--
Dr. Maria L. Maccecchini, Ph.D.
Dr. Maria L. Maccecchini, Ph.D.
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
--
--
Dr. Claudine E. Bruck, Ph.D.
Dr. Claudine E. Bruck, Ph.D.
Independent Director
Independent Director
--
--
Mr. Reid S. Mccarthy
Mr. Reid S. Mccarthy
Independent Director
Independent Director
--
--
Mr. Mark White
Mr. Mark White
Director, Chief Business Officer
Director, Chief Business Officer
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 7月19日 週六
更新時間: 7月19日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Hoffman (Michael B)
8.57%
Maccecchini (Maria-Luisa)
5.72%
Heights Capital Management, Inc.
5.13%
The Vanguard Group, Inc.
3.33%
Two Sigma Investments, LP
1.33%
Other
75.93%
持股股東
持股股東
佔比
Hoffman (Michael B)
8.57%
Maccecchini (Maria-Luisa)
5.72%
Heights Capital Management, Inc.
5.13%
The Vanguard Group, Inc.
3.33%
Two Sigma Investments, LP
1.33%
Other
75.93%
股東類型
持股股東
佔比
Individual Investor
14.69%
Investment Advisor
11.83%
Investment Advisor/Hedge Fund
1.76%
Hedge Fund
1.75%
Research Firm
0.51%
Family Office
0.10%
Bank and Trust
0.05%
Pension Fund
0.03%
Other
69.28%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
103
5.97M
30.62%
-274.28K
2025Q1
104
5.95M
41.64%
-106.94K
2024Q4
93
4.41M
22.61%
-199.92K
2024Q3
85
4.03M
23.62%
-296.86K
2024Q2
80
3.84M
23.67%
-697.75K
2024Q1
77
3.92M
38.68%
-550.67K
2023Q4
77
3.92M
40.01%
-464.08K
2023Q3
81
3.83M
42.48%
-299.71K
2023Q2
104
3.90M
43.31%
-104.02K
2023Q1
106
3.34M
40.86%
-680.15K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Hoffman (Michael B)
1.67M
8.57%
+25.00K
+1.52%
Jun 13, 2025
Maccecchini (Maria-Luisa)
1.11M
5.72%
+46.00K
+4.31%
Jun 04, 2025
Heights Capital Management, Inc.
1.00M
5.13%
--
--
Mar 31, 2025
The Vanguard Group, Inc.
647.92K
3.33%
+181.64K
+38.96%
Mar 31, 2025
Two Sigma Investments, LP
259.14K
1.33%
+248.22K
+2272.43%
Mar 31, 2025
UBS Financial Services, Inc.
160.88K
0.83%
+112.14K
+230.10%
Mar 31, 2025
Geode Capital Management, L.L.C.
152.61K
0.78%
+53.05K
+53.28%
Mar 31, 2025
Susquehanna International Group, LLP
127.70K
0.66%
+72.39K
+130.88%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
99.49K
0.51%
-1.29K
-1.28%
Mar 31, 2025
Consilium Associates
97.82K
0.5%
-700.00
-0.71%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
iShares Micro-Cap ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
iShares Micro-Cap ETF
佔比0%
iShares Core S&P Total U.S. Stock Market ETF
佔比0%
DFA Dimensional US Sustainability Core 1 ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
